EUVIMEDOpdag EUVIMED
Multizentrische StudieOpen access · CC BY-NC-ND 4.0

Dental Adverse Effects Following Multimodality Treatment for Head and Neck Rhabdomyosarcoma: Results of a Trans‐Atlantic Multicentre Study

Koen B Krommenhoek iD, Marinka L F Hol, Olga Slater, Mark N Gaze iD, Willem M M Fennis iD, Frederic J Kolb, Ludwig Smeele, Daniel J Indelicato iD, Reinier C Hoogeveen iD, Alfred G Becking, Johannes H M Merks

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.32004 ↗

At a glance

Multizentrische Studie in Pediatric Blood & Cancer, 2025. Written by Koen B Krommenhoek and 10 co-authors. Institution: Department of Oral and Maxillofacial Surgery, Amsterdam UMC University of Amsterdam, Amsterdam, The Netherlands. Major MEDLINE topics: Head and Neck Neoplasms, Rhabdomyosarcoma, Periodontal Diseases. Cited 3 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Olivia Hodson Cancer Fund, Stichting Kinderen Kankervrij.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

As survival of paediatric cancer improves, more emphasis is placed on late adverse effects. However, the dental and periodontal adverse effects of cancer treatments in children remain an underinvestigated complication. This study aims to investigate the prevalence of late clinical dental adverse effects (cDAE) in survivors of paediatric head and neck rhabdomyosarcoma (HNRMS).

Methods

Between 2017 and 2019, data were collected as part of a collaborative study between four international centres. During a ‘late adverse effect clinic’, dentists examined HNMRS survivors who were treated using multimodality treatments for dental and periodontal adverse effects using the following validated index scores ‘Simplified Oral Hygiene Index’ (SOHI), the ‘Decayed, Missing and Filled Teeth’ (DMFT) score and the ‘Dutch Periodontal Screening Index’ (DPSI).

Results

Forty‐six survivors, with a median follow‐up of 9.9 years (range: 2–29.7 years), were included. Of these survivors of HNRMS, 89.1% had significant plaque accumulation. The median DMFT score was 3.00 (range: 0–26), which is considered normal. However, approximately a quarter of the survivors had exceptionally high DFMT scores, indicating many teeth were missing or filled. Affected gingivae, unhealthy gums, were seen in 67.4% of survivors of HNRMS.

Conclusion

Survivors of HNRMS have higher plaque and gingivitis rates, possibly due to cancer treatment or poor oral hygiene and diet. Next to regular care, additional monitoring of oral health and support of oral hygiene are indicated. Survivors, parents and physicians should be aware of the dental and periodontal risks and ensure proper care is available.

Subjects

MeSH terms (MEDLINE)

Head and Neck NeoplasmsRhabdomyosarcomaPeriodontal DiseasesHumansChildMaleFemaleAdolescentChild, PreschoolCombined Modality TherapyFollow-Up StudiesAdultYoung AdultPrognosisCancer SurvivorsInfant

Author keywords

gingivitisoral hygienepaediatricradiationrhabdomyosarcoma

Authors and institutions

  • Department of Oral and Maxillofacial Surgery, Amsterdam UMC University of Amsterdam, Amsterdam, The Netherlands.
  • Princess Máxima Centre For Paediatric Oncology, Utrecht, The Netherlands.
  • Department of Otolaryngology and Head and Neck Cancer, University of Utrecht, Utrecht, The Netherlands.
  • Department of Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Department of Oral and Maxillofacial Surgery, Prosthodontics and Special Dental Care, University Medical Centre Utrecht, Utrecht, The Netherlands.

ORCID profiles: Koen B Krommenhoek, Mark N Gaze, Willem M M Fennis, Daniel J Indelicato, Reinier C Hoogeveen

Funding

  • Olivia Hodson Cancer Fund
  • Stichting Kinderen Kankervrij

Cite

APA

Krommenhoek, K. B., Hol, M. L. F., Slater, O., Gaze, M. N., Fennis, W. M. M., Kolb, F. J., Smeele, L., Indelicato, D. J., Hoogeveen, R. C., Becking, A. G., & Merks, J. H. M. (2025). Dental Adverse Effects Following Multimodality Treatment for Head and Neck Rhabdomyosarcoma: Results of a Trans‐Atlantic Multicentre Study. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.32004

Vancouver

Krommenhoek KB, Hol MLF, Slater O, Gaze MN, Fennis WMM, Kolb FJ, et al. Dental Adverse Effects Following Multimodality Treatment for Head and Neck Rhabdomyosarcoma: Results of a Trans‐Atlantic Multicentre Study. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.32004

BibTeX
@article{Krommenhoek2025,
  author = {Krommenhoek, Koen B and Hol, Marinka L F and Slater, Olga and Gaze, Mark N and Fennis, Willem M M and Kolb, Frederic J and Smeele, Ludwig and Indelicato, Daniel J and Hoogeveen, Reinier C and Becking, Alfred G and Merks, Johannes H M},
  title = {Dental Adverse Effects Following Multimodality Treatment for Head and Neck Rhabdomyosarcoma: Results of a Trans‐Atlantic Multicentre Study},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.32004}
}
Start for free →